Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 Trial

There is no evidence of an overall significant difference in cost associated with a policy of universal, routine repeat testing, compared to usual care, in women receiving an initial PlGF-based test for suspected pre-eclampsia.

Authors

Institutions

Publication Details

Journal
PharmacoEconomics - Open
Published
2026-01-06
DOI
https://doi.org/10.1007/s41669-025-00629-4
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 Trial

Ashwin Ahuja, Sian McDonnell, Sambita Basak, Beth Peers et al.
PharmacoEconomics - Open
Pregnancy and preeclampsia studies
article

Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 Trial

Ashwin Ahuja, Sian McDonnell, Sambita Basak, Beth Peers, Nikolaos Chados, Mel McBean, Lindsay Roughley, Zoë Vowles, Louise Webster, Natalie Barry, PAUL T. SEED, Lucy Dudgeon, Alice Hurrell, Andrew Shennan, Lynda Verghese, Hazel Alexander, Jenie Sparkes, Cheryl Battersby, Lauren Trepte, Lucy C. Chappell, Mel Rich, Lesley Hewitt, Laura Stirrat, Elaine Jack, Katherine Clark, Siobhan Holt, Grace Ryan, Kate Duhig, Rachael Hunter, Chandrima Biswas, Clare O’Brien, Jenny Myers, Carolyn Gill, Sharon Gowans, Anku Mehta, Linda Bishop, Martin Maher, Brittany Smart, Rita Arya, Chinwe Obiozo, Kim Hinshaw, Maeve Regan, A. Yulia, Katie R. Morris, Jessica Davison, Jacqui Jennings, Annabel N. Smith, F Pickering, R. K. Bahl, Seren Willson, Mihraban Bapir, Orla Ferry, Jo Girling, Hilary Thompson, Sarah Davies, Jo Ficquet, Deniesha Campbell, the PARROT-2 Trial Group, Andrew Sharp, Marcus Green
article en

Abstract

There is no evidence of an overall significant difference in cost associated with a policy of universal, routine repeat testing, compared to usual care, in women receiving an initial PlGF-based test for suspected pre-eclampsia.

PharmacoEconomics - OpenVol. 10(2)
King's College London (GB), Manchester Academic Health Science Centre (GB), Action for ME (GB), Chelsea and Westminster Hospital (GB), University College London (GB), Imperial College London (GB)
National Institute for Health and Care Research, Tommy's
Gender equality
Openalex Percentile: Top 95%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.